British Journal of Clinical Pharmacology · 1986 · 67 citations · 9 references
PharmacyPharmacokineticsPharmacologyBioavailabilityClinical NutritionClinical PharmacologyBody Composition ChangesWeight ManagementBody Composition Effects On Drug DispositionBody Composition Effects On PharmacokineticsBody Weight Effects On PharmacokineticsOral Absorption KineticsPharmacokinetics In ObesityPropranolol TherapySubjectsWeight Management Pharmacokinetics
The pharmacokinetics of intravenous and oral propranolol have been compared in six obese and six normal subjects matched for age and sex. After intravenous administration there was no difference in plasma clearance but the volume of distribution was greater (V = 339 l vs 198 l) and the half-life was longer (t1/2 = 5.0 h vs 3.0 h) in the obese group. No important difference in the rate of oral absorption was observed. A trend towards higher systemic availability in the obese group (35% vs 27%) was not statistically significant.
9
Effect of Age, Gender, and Obesity on Midazolam Kinetics
David J. Greenblatt, Ann Locniskar, Jerold S. Harmatz et al. · Anesthesiology · 1984 · 503 citations
Effect of Age, Gender, and Obesity on Midazolam Kinetics
David J. Greenblatt, Ann Locniskar, Jerold S. Harmatz et al. · Anesthesiology · 1984 · 458 citations
Treat Obesity Seriously. A Clinical Manual
B I Hoffbrand · Postgraduate Medical Journal · 1982 · 153 citations · Full text